The Cytolytic Amphipathic β(2,2)-Amino Acid LTX-401 Induces DAMP Release in Melanoma Cells and Causes Complete Regression of B16 Melanoma.
In the present study we examined the ability of the amino acid derivative LTX-401 to induce cell death in cancer cell lines, as well as the capacity to induce regression in a murine melanoma model. Mode of action studies in vitro revealed lytic cell death and release of danger-associated molecular p...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4755540?pdf=render |
id |
doaj-1defea10541e4d17a3589cd31b8a5dce |
---|---|
record_format |
Article |
spelling |
doaj-1defea10541e4d17a3589cd31b8a5dce2020-11-25T01:35:14ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-01112e014898010.1371/journal.pone.0148980The Cytolytic Amphipathic β(2,2)-Amino Acid LTX-401 Induces DAMP Release in Melanoma Cells and Causes Complete Regression of B16 Melanoma.Liv-Marie EikeBrynjar MausethKetil André CamilioØystein RekdalBaldur SveinbjørnssonIn the present study we examined the ability of the amino acid derivative LTX-401 to induce cell death in cancer cell lines, as well as the capacity to induce regression in a murine melanoma model. Mode of action studies in vitro revealed lytic cell death and release of danger-associated molecular pattern molecules, preceded by massive cytoplasmic vacuolization and compromised lysosomes in treated cells. The use of a murine melanoma model demonstrated that the majority of animals treated with intratumoural injections of LTX-401 showed complete and long-lasting remission. Taken together, these results demonstrate the potential of LTX-401 as an immunotherapeutic agent for the treatment of solid tumors.http://europepmc.org/articles/PMC4755540?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Liv-Marie Eike Brynjar Mauseth Ketil André Camilio Øystein Rekdal Baldur Sveinbjørnsson |
spellingShingle |
Liv-Marie Eike Brynjar Mauseth Ketil André Camilio Øystein Rekdal Baldur Sveinbjørnsson The Cytolytic Amphipathic β(2,2)-Amino Acid LTX-401 Induces DAMP Release in Melanoma Cells and Causes Complete Regression of B16 Melanoma. PLoS ONE |
author_facet |
Liv-Marie Eike Brynjar Mauseth Ketil André Camilio Øystein Rekdal Baldur Sveinbjørnsson |
author_sort |
Liv-Marie Eike |
title |
The Cytolytic Amphipathic β(2,2)-Amino Acid LTX-401 Induces DAMP Release in Melanoma Cells and Causes Complete Regression of B16 Melanoma. |
title_short |
The Cytolytic Amphipathic β(2,2)-Amino Acid LTX-401 Induces DAMP Release in Melanoma Cells and Causes Complete Regression of B16 Melanoma. |
title_full |
The Cytolytic Amphipathic β(2,2)-Amino Acid LTX-401 Induces DAMP Release in Melanoma Cells and Causes Complete Regression of B16 Melanoma. |
title_fullStr |
The Cytolytic Amphipathic β(2,2)-Amino Acid LTX-401 Induces DAMP Release in Melanoma Cells and Causes Complete Regression of B16 Melanoma. |
title_full_unstemmed |
The Cytolytic Amphipathic β(2,2)-Amino Acid LTX-401 Induces DAMP Release in Melanoma Cells and Causes Complete Regression of B16 Melanoma. |
title_sort |
cytolytic amphipathic β(2,2)-amino acid ltx-401 induces damp release in melanoma cells and causes complete regression of b16 melanoma. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2016-01-01 |
description |
In the present study we examined the ability of the amino acid derivative LTX-401 to induce cell death in cancer cell lines, as well as the capacity to induce regression in a murine melanoma model. Mode of action studies in vitro revealed lytic cell death and release of danger-associated molecular pattern molecules, preceded by massive cytoplasmic vacuolization and compromised lysosomes in treated cells. The use of a murine melanoma model demonstrated that the majority of animals treated with intratumoural injections of LTX-401 showed complete and long-lasting remission. Taken together, these results demonstrate the potential of LTX-401 as an immunotherapeutic agent for the treatment of solid tumors. |
url |
http://europepmc.org/articles/PMC4755540?pdf=render |
work_keys_str_mv |
AT livmarieeike thecytolyticamphipathicb22aminoacidltx401inducesdampreleaseinmelanomacellsandcausescompleteregressionofb16melanoma AT brynjarmauseth thecytolyticamphipathicb22aminoacidltx401inducesdampreleaseinmelanomacellsandcausescompleteregressionofb16melanoma AT ketilandrecamilio thecytolyticamphipathicb22aminoacidltx401inducesdampreleaseinmelanomacellsandcausescompleteregressionofb16melanoma AT øysteinrekdal thecytolyticamphipathicb22aminoacidltx401inducesdampreleaseinmelanomacellsandcausescompleteregressionofb16melanoma AT baldursveinbjørnsson thecytolyticamphipathicb22aminoacidltx401inducesdampreleaseinmelanomacellsandcausescompleteregressionofb16melanoma AT livmarieeike cytolyticamphipathicb22aminoacidltx401inducesdampreleaseinmelanomacellsandcausescompleteregressionofb16melanoma AT brynjarmauseth cytolyticamphipathicb22aminoacidltx401inducesdampreleaseinmelanomacellsandcausescompleteregressionofb16melanoma AT ketilandrecamilio cytolyticamphipathicb22aminoacidltx401inducesdampreleaseinmelanomacellsandcausescompleteregressionofb16melanoma AT øysteinrekdal cytolyticamphipathicb22aminoacidltx401inducesdampreleaseinmelanomacellsandcausescompleteregressionofb16melanoma AT baldursveinbjørnsson cytolyticamphipathicb22aminoacidltx401inducesdampreleaseinmelanomacellsandcausescompleteregressionofb16melanoma |
_version_ |
1725067691850465280 |